The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Important Content Reminder:
- Implementation status of the second phase buyback plan: As of March 31, 2026, Hangzhou Minsheng Health Pharmaceutical Co., Ltd. (hereinafter referred to as "the company") has cumulatively repurchased 2,105,100 shares through a dedicated securities account via centralized bidding, accounting for 0.59% of the company's total share capital. The highest transaction price was 15.67 RMB/share, the lowest transaction price was 14.22 RMB/share, and the total payment amount was 31,476,595 RMB (excluding transaction fees).